DZ-191

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameDZ-191
Drug Alias Namesimvastatin-heptarnethine carbocyanine conjugate (Cedars-Sinai Medical Center/Sichuan University)DZ-191
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesCedars-Sinai Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsLung Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A